GENSCI Trademark

Trademark Overview

On Friday, June 24, 2022, a trademark application was filed for GENSCI with the United States Patent and Trademark Office. The USPTO has given the GENSCI trademark a serial number of 79349335. The federal status of this trademark filing is REGISTERED as of Tuesday, January 30, 2024. This trademark is owned by CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD.. The GENSCI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of growth hormone deficiency in adults and children, and female reproductive disorders; hormones for medical purposes; medicines for human purposes for treatment of growth hormone deficiency in adults and children, and female reproductive disorders; crude drugs for treatment of growth hormone deficiency in adults and children, and female reproductive disorders; chemical conductors for electrocardiograph electrodes
gensci

General Information

Serial Number79349335
Word MarkGENSCI
Filing DateFriday, June 24, 2022
Status700 - REGISTERED
Status DateTuesday, January 30, 2024
Registration Number7292334
Registration DateTuesday, January 30, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 14, 2023

Trademark Statements

Description of MarkThe mark consists of the wording GENSCI to the right of a design of a double helix.
Goods and ServicesPharmaceutical preparations for the treatment of growth hormone deficiency in adults and children, and female reproductive disorders; hormones for medical purposes; medicines for human purposes for treatment of growth hormone deficiency in adults and children, and female reproductive disorders; crude drugs for treatment of growth hormone deficiency in adults and children, and female reproductive disorders; chemical conductors for electrocardiograph electrodes
Pseudo MarkGEN SCI

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN
Party NameCHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN
Party NameCHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events

Event DateEvent Description
Thursday, September 15, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 20, 2022APPLICATION FILING RECEIPT MAILED
Sunday, April 9, 2023ASSIGNED TO EXAMINER
Monday, April 10, 2023NON-FINAL ACTION WRITTEN
Tuesday, April 11, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 6, 2023REFUSAL PROCESSED BY MPU
Tuesday, June 6, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, June 26, 2023REFUSAL PROCESSED BY IB
Friday, September 15, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 6, 2023EXAMINERS AMENDMENT -WRITTEN
Friday, October 6, 2023EXAMINERS AMENDMENT E-MAILED
Friday, October 6, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 6, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, October 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 25, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, November 13, 2023NOTIFICATION PROCESSED BY IB
Tuesday, November 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 30, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, April 30, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, May 1, 2024GENERIC MADRID TRANSACTION SENT TO IB
Wednesday, May 1, 2024GENERIC MADRID TRANSACTION CREATED
Tuesday, January 30, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, June 17, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, September 14, 2024CORRECTION TRANSACTION RECEIVED FROM IB
Friday, November 8, 2024CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, January 23, 2025CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Tuesday, March 11, 2025CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED

Related Keywords

gensci adults children female reproductive deficiency disorders treatment growth hormone purposes